About the Data
Our data allows us to experiment with the longitudinal immune response of individuals, as it generates time-series data from various omics on a per-patient basis.
Clinical data
We collected laboratary and vital sign data for 443 patients infected with SARS-CoV-2, up to a maximum of 30 days after admission.
WGS data
We collected Whole-Genome Sequence (WGS) data for a total of 620 individuals, including 459 patients infected with SARS-CoV-2 at the time of admission and 161 individuals from a control group.
COVID-seq data
We collected COVID-seq data for 434 patients infected with SARS-CoV-2 at the time of admission.
HLA typing data
We collected HLA-typing data for a total of 620 individuals, including 459 patients infected with SARS-CoV-2 at the time of admission and 161 individuals from a healthy control group.
Cytokine data
We collected 1,159 samples, including 1,014 longitudinal samples from patients infected with SARS-CoV-2 and 145 samples from a healthy control group.
scRNA-seq data
We collected 708 samples, including 593 longitudinal samples from patients infected with SARS-CoV-2 and 115 samples from a healthy control group.